
Suzanne Marie Noakes
Examiner (ID: 17824)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1691 |
| Issued Applications | 1090 |
| Pending Applications | 193 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20059615
[patent_doc_number] => 20250197837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/069321
[patent_app_country] => US
[patent_app_date] => 2025-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19069321
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/069321 | SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF | Mar 3, 2025 | Pending |
Array
(
[id] => 20121816
[patent_doc_number] => 20250236847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 19/060404
[patent_app_country] => US
[patent_app_date] => 2025-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19060404
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/060404 | COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION | Feb 20, 2025 | Pending |
Array
(
[id] => 19877138
[patent_doc_number] => 20250109395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME
[patent_app_type] => utility
[patent_app_number] => 18/970552
[patent_app_country] => US
[patent_app_date] => 2024-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18970552
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/970552 | S. pyogenes CAS9 mutant genes and polypeptides encoded by same | Dec 4, 2024 | Issued |
Array
(
[id] => 19855764
[patent_doc_number] => 12258588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/919946
[patent_app_country] => US
[patent_app_date] => 2024-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 9
[patent_no_of_words] => 13318
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/919946 | Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof | Oct 17, 2024 | Issued |
Array
(
[id] => 19877133
[patent_doc_number] => 20250109390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => COMPOSITIONS FOR PREVENTING OR TREATING CORONAVIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/914016
[patent_app_country] => US
[patent_app_date] => 2024-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18914016
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/914016 | Compositions for preventing or treating coronavirus infections | Oct 10, 2024 | Issued |
Array
(
[id] => 19809737
[patent_doc_number] => 12241109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Host cells comprising a recombinant casein protein and a recombinant kinase protein
[patent_app_type] => utility
[patent_app_number] => 18/886925
[patent_app_country] => US
[patent_app_date] => 2024-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 43
[patent_no_of_words] => 90167
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18886925
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/886925 | Host cells comprising a recombinant casein protein and a recombinant kinase protein | Sep 15, 2024 | Issued |
Array
(
[id] => 19682411
[patent_doc_number] => 20250000956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => RECOMBINANT CELL WALL HYDROLASES
[patent_app_type] => utility
[patent_app_number] => 18/882318
[patent_app_country] => US
[patent_app_date] => 2024-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882318
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/882318 | Recombinant cell wall hydrolases | Sep 10, 2024 | Issued |
Array
(
[id] => 19631460
[patent_doc_number] => 20240409909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => ALPHA-AMYLASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/774233
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774233
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774233 | ALPHA-AMYLASE VARIANTS | Jul 15, 2024 | Pending |
Array
(
[id] => 19746032
[patent_doc_number] => 20250034597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci
[patent_app_type] => utility
[patent_app_number] => 18/764634
[patent_app_country] => US
[patent_app_date] => 2024-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18764634
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/764634 | RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci | Jul 4, 2024 | Pending |
Array
(
[id] => 19631432
[patent_doc_number] => 20240409881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => METHOD FOR EXPANDING PROPAGATION OF METARHIZIUM RILEYI MR006 AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/734239
[patent_app_country] => US
[patent_app_date] => 2024-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18734239
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/734239 | Method for expanding propagation of | Jun 4, 2024 | Issued |
Array
(
[id] => 19528538
[patent_doc_number] => 20240352440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => ENZYMATIC PRODUCTION OF HEXOSES
[patent_app_type] => utility
[patent_app_number] => 18/641530
[patent_app_country] => US
[patent_app_date] => 2024-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641530
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/641530 | ENZYMATIC PRODUCTION OF HEXOSES | Apr 21, 2024 | Pending |
Array
(
[id] => 19528538
[patent_doc_number] => 20240352440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => ENZYMATIC PRODUCTION OF HEXOSES
[patent_app_type] => utility
[patent_app_number] => 18/641530
[patent_app_country] => US
[patent_app_date] => 2024-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641530
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/641530 | ENZYMATIC PRODUCTION OF HEXOSES | Apr 21, 2024 | Pending |
Array
(
[id] => 19345553
[patent_doc_number] => 20240254516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => COMPLEX FOR GENOME EDITING HAVING STABILITY AND FEW SIDE-EFFECTS, AND NUCLEIC ACID CODING SAME
[patent_app_type] => utility
[patent_app_number] => 18/634640
[patent_app_country] => US
[patent_app_date] => 2024-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18634640
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/634640 | COMPLEX FOR GENOME EDITING HAVING STABILITY AND FEW SIDE-EFFECTS, AND NUCLEIC ACID CODING SAME | Apr 11, 2024 | Pending |
Array
(
[id] => 19474011
[patent_doc_number] => 12104088
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-10-01
[patent_title] => Bone gelatin process
[patent_app_type] => utility
[patent_app_number] => 18/614665
[patent_app_country] => US
[patent_app_date] => 2024-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2658
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 302
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18614665
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/614665 | Bone gelatin process | Mar 22, 2024 | Issued |
Array
(
[id] => 19770315
[patent_doc_number] => 20250051741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => OMNI-103 CRISPR NUCLEASE
[patent_app_type] => utility
[patent_app_number] => 18/613508
[patent_app_country] => US
[patent_app_date] => 2024-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613508
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/613508 | OMNI-103 CRISPR NUCLEASE | Mar 21, 2024 | Pending |
Array
(
[id] => 19770315
[patent_doc_number] => 20250051741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => OMNI-103 CRISPR NUCLEASE
[patent_app_type] => utility
[patent_app_number] => 18/613508
[patent_app_country] => US
[patent_app_date] => 2024-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613508
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/613508 | OMNI-103 CRISPR NUCLEASE | Mar 21, 2024 | Pending |
Array
(
[id] => 19404056
[patent_doc_number] => 20240287567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => ENZYMATIC METHOD FOR PREPARING REBAUDIOSIDE J
[patent_app_type] => utility
[patent_app_number] => 18/600332
[patent_app_country] => US
[patent_app_date] => 2024-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600332
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/600332 | ENZYMATIC METHOD FOR PREPARING REBAUDIOSIDE J | Mar 7, 2024 | Abandoned |
Array
(
[id] => 19249060
[patent_doc_number] => 20240200047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ENZYMES WITH RUVC DOMAINS
[patent_app_type] => utility
[patent_app_number] => 18/586929
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18586929
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/586929 | Enzymes with RUVC domains | Feb 25, 2024 | Issued |
Array
(
[id] => 19389761
[patent_doc_number] => 20240279631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => Chimeric endolysin polypeptide
[patent_app_type] => utility
[patent_app_number] => 18/582803
[patent_app_country] => US
[patent_app_date] => 2024-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18582803
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/582803 | Chimeric endolysin polypeptide | Feb 20, 2024 | Issued |
Array
(
[id] => 19361148
[patent_doc_number] => 20240263182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => METHODS AND MICROORGANISMS FOR MAKING 2,3-BUTANEDIOL AND DERIVATIVES THEREOF FROM C1 CARBONS
[patent_app_type] => utility
[patent_app_number] => 18/582362
[patent_app_country] => US
[patent_app_date] => 2024-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18582362
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/582362 | METHODS AND MICROORGANISMS FOR MAKING 2,3-BUTANEDIOL AND DERIVATIVES THEREOF FROM C1 CARBONS | Feb 19, 2024 | Pending |